Bibliographic Details
| Title: |
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study |
| Authors: |
Carlo-Stella, Carmelo, Delarue, Richard, Scarfo, Lydia, Barde, Prajak J., Nair, Ajit, Locatelli, Silvia L., Morello, Lucia, Magagnoli, Massimo, Vakkalanka, Swaroop, Viswanadha, Srikant, Ferreri, Andrés J.M. |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia February 2020 20(2):78-86 |
| Database: |
ScienceDirect |
